Insulet Executive and Leadership Team

Ashley McEvoy, the Director, President & Chief Executive Officer at Insulet, directs the overarching strategic vision for the Omnipod product platform. By prioritizing innovation in wearable medical devices, the Director, President & Chief Executive Officer ensures the company maintains a competitive edge in the diabetes management market. This leadership role involves coordinating with the Board to align operational goals with long-term growth objectives. Ashley McEvoy drives the expansion of subcutaneous drug delivery technologies, ensuring that the organization addresses unmet patient needs across North American and international markets. Through rigorous oversight of corporate initiatives, the Director, President & Chief Executive Officer fosters a culture of excellence and technological advancement. By optimizing resource allocation and market penetration strategies, the executive secures the company's position as a leader in medical device manufacturing. Ultimately, the Director, President & Chief Executive Officer sustains the commitment to improving patient outcomes through simplified, needle-free insulin delivery solutions.

Carsten Boess, the Chief Financial Officer at Insulet, manages the fiscal health and capital allocation strategies necessary for scaling the Omnipod platform. Overseeing financial planning and analysis, the Chief Financial Officer ensures that investment in research and development aligns with the company's mission to simplify diabetes care. This role requires constant collaboration with executive leadership to evaluate market opportunities and mitigate financial risks associated with global medical device manufacturing. Carsten Boess directs the budgeting processes that support the expansion of subcutaneous drug delivery systems into new therapeutic areas. By maintaining rigorous financial controls, the Chief Financial Officer provides the stability required for sustained innovation. The executive monitors economic trends across international markets to inform strategic decision-making. Through precise financial reporting and investor relations, the Chief Financial Officer strengthens the company's market position. Ultimately, the Chief Financial Officer drives the financial discipline that enables the organization to deliver life-changing technology to patients worldwide.

Ana Chadwick, the Executive Vice President & Chief Financial Officer & Treasurer at Insulet, manages the company's treasury operations and capital structure to support the growth of the Omnipod platform. Overseeing liquidity and financial risk management, the Executive Vice President & Chief Financial Officer & Treasurer ensures that the organization maintains the resources needed for global expansion. This role involves coordinating with the finance department to optimize cash flow and investment strategies. Ana Chadwick directs the treasury functions that safeguard the company's assets while funding research into new subcutaneous drug delivery applications. By analyzing market conditions, the Executive Vice President & Chief Financial Officer & Treasurer provides the strategic insights necessary for long-term financial health. The executive collaborates with the Board to ensure transparency and compliance in all financial activities. Through disciplined management of capital, the Executive Vice President & Chief Financial Officer & Treasurer supports the company's mission to innovate in the medical device industry. Ultimately, the Executive Vice President & Chief Financial Officer & Treasurer drives the financial stability required for sustained market leadership.

Timothy Stonesifer, the Chief Financial Officer, At Alcon Inc at Insulet, provides specialized financial oversight to ensure the company's fiscal strategies align with the complexities of the medical device manufacturing industry. Overseeing financial reporting and cost management, the Chief Financial Officer, At Alcon Inc ensures that resources are directed toward the most impactful research and development projects. This role involves evaluating the financial viability of expanding the Omnipod technology into new therapeutic areas. Timothy Stonesifer directs the financial analysis that supports the company's competitive positioning in global markets. By monitoring operational costs and revenue streams, the Chief Financial Officer, At Alcon Inc maintains the financial health necessary for continuous innovation. The executive collaborates with the leadership team to refine business models and improve profitability. Through strategic financial planning, the Chief Financial Officer, At Alcon Inc supports the organization's mission to simplify diabetes management. Ultimately, the Chief Financial Officer, At Alcon Inc drives the financial rigor that enables the company to deliver high-quality medical solutions to patients.

Jane Hoffman, the Corporate Affairs Chief of Staff at Insulet, coordinates internal communications and strategic initiatives to support the company's mission in the medical device sector. Managing the flow of information between departments, the Corporate Affairs Chief of Staff ensures that organizational goals remain transparent and actionable. This leadership role involves aligning corporate messaging with the technological advancements of the Omnipod platform. Jane Hoffman facilitates cross-functional collaboration to streamline operations and enhance the company's public profile. By overseeing corporate affairs, the Corporate Affairs Chief of Staff strengthens relationships with key stakeholders and industry partners. The executive drives initiatives that promote the benefits of needle-free insulin delivery to broader patient populations. Through effective project management and strategic planning, the Corporate Affairs Chief of Staff supports the executive team in executing long-term growth strategies. Ultimately, the Corporate Affairs Chief of Staff ensures that the company's internal culture and external reputation reflect the commitment to innovation and patient-centric care.

Rakesh Pant, the Staff Software Engineer & Chief Technology Officer, Cloud Data Products at Insulet, architects the digital infrastructure supporting the Omnipod insulin management system. Overseeing the development of cloud-based data solutions, the Staff Software Engineer & Chief Technology Officer, Cloud Data Products ensures that patient data remains secure and accessible. This role involves integrating advanced software capabilities into wearable medical devices to improve user experience and clinical outcomes. Rakesh Pant directs the engineering teams responsible for building scalable data platforms that facilitate real-time monitoring and analysis. By leveraging cloud technology, the Staff Software Engineer & Chief Technology Officer, Cloud Data Products enhances the functionality of the company's product portfolio. The executive collaborates with other technical leaders to ensure that software innovations align with regulatory standards and medical requirements. Through continuous improvement of digital products, the Staff Software Engineer & Chief Technology Officer, Cloud Data Products drives the technological evolution of the company's offerings. Ultimately, the Staff Software Engineer & Chief Technology Officer, Cloud Data Products secures the digital future of the organization.

Nikkole DeMars, the Director, E2E CX Planning and Operations (Chief of Staff To GVP of E2E CX) at Insulet, optimizes the end-to-end customer experience for users of the Omnipod system. Overseeing operational planning, the Director, E2E CX Planning and Operations (Chief of Staff To GVP of E2E CX) ensures that service delivery remains seamless and efficient across all patient touchpoints. This role involves aligning customer support strategies with the company's technological advancements. Nikkole DeMars directs the operational workflows that support the adoption of wearable insulin delivery devices. By analyzing customer feedback and operational data, the Director, E2E CX Planning and Operations (Chief of Staff To GVP of E2E CX) identifies opportunities to enhance service quality and patient satisfaction. The executive collaborates with cross-functional teams to implement improvements that streamline the user journey. Through rigorous planning and execution, the Director, E2E CX Planning and Operations (Chief of Staff To GVP of E2E CX) supports the company's commitment to patient-centric care. Ultimately, the Director, E2E CX Planning and Operations (Chief of Staff To GVP of E2E CX) drives operational excellence in customer engagement.

Trang Ly, the Senior Vice President, Chief Medical Officer at Insulet, leads the clinical strategy and medical research initiatives for the Omnipod product platform. Overseeing clinical trials and medical affairs, the Senior Vice President, Chief Medical Officer ensures that all technological developments meet the highest standards of safety and efficacy for patients with diabetes. This role involves collaborating with regulatory bodies and healthcare providers to validate the clinical benefits of needle-free insulin delivery. Trang Ly directs the medical team in exploring new applications for subcutaneous drug delivery across diverse therapeutic areas. By integrating clinical insights into product design, the Senior Vice President, Chief Medical Officer enhances the overall impact of the company's medical devices. The executive monitors global health trends to inform the development of future innovations. Through rigorous clinical oversight, the Senior Vice President, Chief Medical Officer supports the company's mission to improve patient quality of life. Ultimately, the Senior Vice President, Chief Medical Officer drives the medical excellence that defines the organization's market presence.